Skip to main content

Holiday schedule

Our Patient Service Centers will be closed on Wednesday, December 25, 2024 in observance of Christmas and Wednesday, January 1, 2025 in observance of New Year's Day. Have a healthy, happy holiday.

Hide
Quest Diagnostics

Systematic Evidence Review and Meta-analysis of Outcomes Associated With Cancer Genetic Counseling

Systematic Evidence Review and Meta-analysis of Outcomes Associated With Cancer Genetic Counseling

Authors: Culver JO, Bertsch NL, Kurz RN, Cheng L, Pritzlaff M, Rao SK, Stasi SM, Stave CD, Sharaf RN

Citation: Genet Med. 2023 Sep 6:100980. doi: 10.1016/j.gim.2023.100980. Online ahead of print

Specialties: Genetics, Oncology

Related content

On-Demand Webinar
Hereditary Cancer Care Starts in Primary Care
Audio Podcast
Optimize Oncology Care with Clinical Pathways
Audio Podcast
Exploring Digital Pathology and Artificial Intelligence
Conference Presentation
Moving in the fast lane test design and validation to produce up to date hereditary breast and gynecologic cancer tests

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.